Demystifying the Evolving Science and Potential Role of Incretins in T2D In this episode, Kristin Gusack, RD will interview Bernhard Ludvik, MD and Thomas Forst, MD. They will discuss the practical a

Clinical Perspectives on Dual Checkpoint Blockade for mNSCLC Dual checkpoint blockade is becoming a more common approach for patients with mNSCLC and no targetable driver mutation, and a new regimen w

Potential Benefits of Incretins Beyond Glycemic Control in T2D In this episode, Kristin Gusack interviews Dr. Juan Frias and Dr. Stefano Del Prado. They discuss the practical application of data and

In this episode, Kristin M. Gusack, RD, CHCP, Executive Director at Medical Learning Institute, Inc., invites Amanda Steinmayr, Senior Director of Educational Strategy to introduce and discuss the new